{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:36Z","timestamp":1790741796091,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,10,6]]},"DOI":"10.1038\/s41388-023-02816-1","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T07:02:04Z","timestamp":1693033324000},"page":"3062-3074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["WNT2\u2013SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiang-Yu","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui-Mian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Xiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1817-803X","authenticated-orcid":false,"given":"Xiao-Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2643-6278","authenticated-orcid":false,"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"2816_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2816_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1470-2045(20)30025-5","volume":"21","author":"EC Smyth","year":"2020","unstructured":"Smyth EC. Chemotherapy for resectable microsatellite instability-high gastric cancer? Lancet Oncol. 2020;21:204.","journal-title":"Lancet Oncol"},{"key":"2816_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1634\/theoncologist.10-90003-49","volume":"10","author":"JA Ajani","year":"2005","unstructured":"Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005;10:49\u201358.","journal-title":"Oncologist"},{"key":"2816_CR4","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1200\/JCO.2007.15.2603","volume":"26","author":"S Takaishi","year":"2008","unstructured":"Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol. 2008;26:2876\u201382.","journal-title":"J Clin Oncol"},{"key":"2816_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager BC, Xie Q, Bao S, Rich JN. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell. 2019;24:41\u201353.","journal-title":"Cell Stem Cell"},{"key":"2816_CR6","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","volume":"3","author":"JA Ajani","year":"2017","unstructured":"Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Prim. 2017;3:17036.","journal-title":"Nat Rev Dis Prim."},{"key":"2816_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00535-015-1125-5","volume":"51","author":"D Brungs","year":"2016","unstructured":"Brungs D, Aghmesheh M, Vine KL, Becker TM, Carolan MG, Ranson M. Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol. 2016;51:313\u201326.","journal-title":"J Gastroenterol"},{"key":"2816_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.bjc.6604437","volume":"99","author":"LM Smith","year":"2008","unstructured":"Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, et al. CD133\/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer. 2008;99:100\u20139.","journal-title":"Br J Cancer"},{"key":"2816_CR9","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-14-0011","volume":"20","author":"C Yoon","year":"2014","unstructured":"Yoon C, Park DJ, Schmidt B, Thomas NJ, Lee H-J, Kim TS, et al. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Clin Cancer Res. 2014;20:3974\u201388.","journal-title":"Clin Cancer Res"},{"key":"2816_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4161\/mabs.27415","volume":"6","author":"DJ Vugts","year":"2014","unstructured":"Vugts DJ, Heuveling DA, Stigter-van Walsum M, Weigand S, Bergstrom M, van Dongen GAMS, et al. Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studies. MAbs. 2014;6:567\u201375.","journal-title":"MAbs."},{"key":"2816_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nature06835","volume":"452","author":"I Malanchi","year":"2008","unstructured":"Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008;452:650\u20133.","journal-title":"Nature."},{"key":"2816_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","volume":"24","author":"C Saygin","year":"2019","unstructured":"Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24:25\u201340.","journal-title":"Cell Stem Cell"},{"key":"2816_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003\u20137.","journal-title":"Nature."},{"key":"2816_CR14","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1158\/0008-5472.CAN-09-0654","volume":"69","author":"M Munz","year":"2009","unstructured":"Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 2009;69:5627\u20139.","journal-title":"Cancer Res"},{"key":"2816_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.","journal-title":"Signal Transduct Target Ther"},{"key":"2816_CR16","first-page":"153","volume":"12","author":"BZ Vider","year":"1996","unstructured":"Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, et al. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene. 1996;12:153\u20138.","journal-title":"Oncogene."},{"key":"2816_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ijc.21160","volume":"117","author":"J Mazieres","year":"2005","unstructured":"Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, et al. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer. 2005;117:326\u201332.","journal-title":"Int J Cancer"},{"key":"2816_CR18","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1038\/s41388-019-0933-0","volume":"38","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang X, Li Z, Wang W, Li B, Huang X, et al. Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer. Oncogene. 2019;38:6985\u20137001.","journal-title":"Oncogene."},{"key":"2816_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-020-01791-9","volume":"40","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang X, Xu P, Wang H, Wang S, Zhang L, et al. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2\/\u03b2-catenin pathway. J Exp Clin Cancer Res. 2021;40:6.","journal-title":"J Exp Clin Cancer Res"},{"key":"2816_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.canlet.2004.11.013","volume":"223","author":"X-X Cheng","year":"2005","unstructured":"Cheng X-X, Wang Z-C, Chen X-Y, Sun Y, Kong Q-Y, Liu J, et al. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Lett. 2005;223:339\u201347.","journal-title":"Cancer Lett"},{"key":"2816_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.devcel.2009.06.005","volume":"17","author":"AM Goss","year":"2009","unstructured":"Goss AM, Tian Y, Tsukiyama T, Cohen ED, Zhou D, Lu MM, et al. Wnt2\/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell. 2009;17:290\u20138.","journal-title":"Dev Cell"},{"key":"2816_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.stem.2007.10.005","volume":"1","author":"JCY Wang","year":"2007","unstructured":"Wang JCY. Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm. Cell Stem Cell. 2007;1:497\u2013501.","journal-title":"Cell Stem Cell"},{"key":"2816_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124\u201334.","journal-title":"Nat Med"},{"key":"2816_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-0035-1558404","volume":"33","author":"M Kahn","year":"2015","unstructured":"Kahn M. Wnt signaling in stem cells and tumor stem cells. Semin Reprod Med. 2015;33:317\u201325.","journal-title":"Semin Reprod Med"},{"key":"2816_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/gutjnl-2020-322924","volume":"71","author":"T-X Huang","year":"2022","unstructured":"Huang T-X, Tan X-Y, Huang H-S, Li Y-T, Liu B-L, Liu K-S, et al. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut. 2022;71:333\u201344.","journal-title":"Gut."},{"key":"2816_CR26","doi-asserted-by":"publisher","first-page":"19306","DOI":"10.18632\/aging.203272","volume":"13","author":"L Jin","year":"2021","unstructured":"Jin L, Luo C, Wu X, Li M, Wu S, Feng Y. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p. Aging. 2021;13:19306\u201316.","journal-title":"Aging"},{"key":"2816_CR27","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1158\/1078-0432.CCR-13-2549","volume":"19","author":"CL Arteaga","year":"2013","unstructured":"Arteaga CL. Progress in breast cancer: overview. Clin Cancer Res. 2013;19:6353\u20139.","journal-title":"Clin Cancer Res"},{"key":"2816_CR28","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1038\/onc.2017.144","volume":"36","author":"N Kramer","year":"2017","unstructured":"Kramer N, Schm\u00f6llerl J, Unger C, Nivarthi H, Rudisch A, Unterleuthner D, et al. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression. Oncogene. 2017;36:5460\u201372.","journal-title":"Oncogene."},{"key":"2816_CR29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1158\/0008-5472.CAN-20-2756","volume":"81","author":"N Grunberg","year":"2021","unstructured":"Grunberg N, Pevsner-Fischer M, Goshen-Lago T, Diment J, Stein Y, Lavon H, et al. Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles. Cancer Res. 2021;81:1639\u201353.","journal-title":"Cancer Res"},{"key":"2816_CR30","doi-asserted-by":"publisher","first-page":"17635","DOI":"10.1002\/jcb.29031","volume":"120","author":"L Lin","year":"2019","unstructured":"Lin L, Wei H, Yi J, Xie B, Chen J, Zhou C, et al. Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells. J Cell Biochem. 2019;120:17635\u201349.","journal-title":"J Cell Biochem"},{"key":"2816_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","volume":"67","author":"CS Moreno","year":"2020","unstructured":"Moreno CS. SOX4: the unappreciated oncogene. Semin Cancer Biol. 2020;67:57\u201364.","journal-title":"Semin Cancer Biol"},{"key":"2816_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/0008-5472.CAN-08-3415","volume":"69","author":"CD Scharer","year":"2009","unstructured":"Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 2009;69:709\u201317.","journal-title":"Cancer Res"},{"key":"2816_CR33","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1128\/MCB.02179-06","volume":"27","author":"D Sinner","year":"2007","unstructured":"Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin S-CJ, et al. Sox17 and Sox4 differentially regulate beta-catenin\/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol. 2007;27:7802\u201315.","journal-title":"Mol Cell Biol"},{"key":"2816_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gendis.2017.12.005","volume":"5","author":"X Peng","year":"2018","unstructured":"Peng X, Liu G, Peng H, Chen A, Zha L, Wang Z. SOX4 contributes to TGF-\u03b2-induced epithelial\u2013mesenchymal transition and stem cell characteristics of gastric cancer cells. Genes Dis. 2018;5:49\u201361.","journal-title":"Genes Dis"},{"key":"2816_CR35","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461\u201373.","journal-title":"Oncogene."},{"key":"2816_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"L Vermeulen","year":"2010","unstructured":"Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12:468\u201376.","journal-title":"Nat Cell Biol"},{"key":"2816_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.canlet.2017.05.029","volume":"402","author":"Q Li","year":"2017","unstructured":"Li Q, Ye L, Zhang X, Wang M, Lin C, Huang S, et al. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt\/\u03b2-catenin signaling. Cancer Lett. 2017;402:166\u201376.","journal-title":"Cancer Lett"},{"key":"2816_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:167\u201392.","journal-title":"J Natl Compr Canc Netw"},{"key":"2816_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"F Wang","year":"2021","unstructured":"Wang F, Zhang X, Li Y, Tang L, Qu X, Ying J, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41:747\u201395.","journal-title":"Cancer Commun"},{"key":"2816_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340.","journal-title":"Lancet."},{"key":"2816_CR41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1073\/pnas.1816262116","volume":"116","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhang H, Ghia EM, Huang J, Wu L, Zhang J, et al. Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody. Proc Natl Acad Sci. 2019;116:1370\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"2816_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014;13:513\u201332.","journal-title":"Nat Rev Drug Discov"},{"key":"2816_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10:717\u201328.","journal-title":"Cell Stem Cell"},{"key":"2816_CR44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, Monge C, Yang Y, Takebe N. Targeting signalling pathways and the immune microenvironment of cancer stem cells \u2014 a clinical update. Nat Rev Clin Oncol. 2020;17:204\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"2816_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12094-015-1337-4","volume":"18","author":"J Chen","year":"2016","unstructured":"Chen J, Ju HL, Yuan XY, Wang TJ, Lai BQ. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis. Clin Transl Oncol. 2016;18:65\u201372.","journal-title":"Clin Transl Oncol"},{"key":"2816_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cr.2011.109","volume":"22","author":"T Chen","year":"2012","unstructured":"Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F, et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res. 2012;22:248\u201358.","journal-title":"Cell Res"},{"key":"2816_CR47","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jcp.48.9.876","volume":"48","author":"S Detre","year":"1995","unstructured":"Detre S, Saclani Jotti G, Dowsett MA. \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48:876\u20138.","journal-title":"J Clin Pathol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02816-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:16:00Z","timestamp":1696533360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02816-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":47,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023,10,6]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1038\/s41388-023-02816-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2279702\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}